Novel chimeric gene therapy vectors based on adeno-associated virus and four different Mammalian bocaviruses
Parvoviruses are highly attractive templates for the engineering of safe, efficient, and specific gene therapy vectors, as best exemplified by adeno-associated virus (AAV). Another candidate that currently garners increasing attention is human bocavirus 1 (HBoV1). Notably, HBoV1 capsids can cross-pa...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
18 January 2019
|
| In: |
Molecular therapy. Methods & clinical development
Year: 2019, Jahrgang: 12, Pages: 202-222 |
| ISSN: | 2329-0501 |
| DOI: | 10.1016/j.omtm.2019.01.003 |
| Online-Zugang: | Verlag, Volltext: https://doi.org/10.1016/j.omtm.2019.01.003 Verlag, Volltext: http://www.sciencedirect.com/science/article/pii/S2329050119300063 
|
| Verfasserangaben: | Julia Fakhiri, Marc A. Schneider, Jens Puschhof, Megan Stanifer, Verena Schildgen, Stefan Holderbach, Yannik Voss, Jihad El Andari, Oliver Schildgen, Steeve Boulant, Michael Meister, Hans Clevers, Ziying Yan, Jianming Qiu, and Dirk Grimm |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1663218870 | ||
| 003 | DE-627 | ||
| 005 | 20240323101132.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 190415s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.omtm.2019.01.003 |2 doi | |
| 035 | |a (DE-627)1663218870 | ||
| 035 | |a (DE-599)KXP1663218870 | ||
| 035 | |a (OCoLC)1341209520 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Fakhiri, Julia |d 1989- |e VerfasserIn |0 (DE-588)1160790612 |0 (DE-627)1024225348 |0 (DE-576)506201422 |4 aut | |
| 245 | 1 | 0 | |a Novel chimeric gene therapy vectors based on adeno-associated virus and four different Mammalian bocaviruses |c Julia Fakhiri, Marc A. Schneider, Jens Puschhof, Megan Stanifer, Verena Schildgen, Stefan Holderbach, Yannik Voss, Jihad El Andari, Oliver Schildgen, Steeve Boulant, Michael Meister, Hans Clevers, Ziying Yan, Jianming Qiu, and Dirk Grimm |
| 264 | 1 | |c 18 January 2019 | |
| 300 | |a 21 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Available online 18 January 2019 | ||
| 500 | |a Gesehen am 15.04.2019 | ||
| 520 | |a Parvoviruses are highly attractive templates for the engineering of safe, efficient, and specific gene therapy vectors, as best exemplified by adeno-associated virus (AAV). Another candidate that currently garners increasing attention is human bocavirus 1 (HBoV1). Notably, HBoV1 capsids can cross-package recombinant (r)AAV2 genomes, yielding rAAV2/HBoV1 chimeras that specifically transduce polarized human airway epithelia (pHAEs). Here, we largely expanded the repertoire of rAAV/BoV chimeras, by assembling packaging plasmids encoding the capsid genes of four additional primate bocaviruses, HBoV2-4 and GBoV (Gorilla BoV). Capsid protein expression and efficient rAAV cross-packaging were validated by immunoblotting and qPCR, respectively. Interestingly, not only HBoV1 but also HBoV4 and GBoV transduced pHAEs as well as primary human lung organoids. Flow cytometry analysis of pHAEs revealed distinct cellular specificities between the BoV isolates, with HBoV1 targeting ciliated, club, and KRT5+ basal cells, whereas HBoV4 showed a preference for KRT5+ basal cells. Surprisingly, primary human hepatocytes, skeletal muscle cells, and T cells were also highly amenable to rAAV/BoV transduction. Finally, we adapted our pipeline for AAV capsid gene shuffling to all five BoV isolates. Collectively, our chimeric rAAV/BoV vectors and bocaviral capsid library represent valuable new resources to dissect BoV biology and to breed unique gene therapy vectors. | ||
| 650 | 4 | |a AAV | |
| 650 | 4 | |a adeno-associated virus | |
| 650 | 4 | |a bocavirus | |
| 650 | 4 | |a BoV | |
| 650 | 4 | |a capsid engineering | |
| 700 | 1 | |a Schneider, Marc |d 1982- |e VerfasserIn |0 (DE-588)140634401 |0 (DE-627)620239948 |0 (DE-576)319208095 |4 aut | |
| 700 | 1 | |a Stanifer, Megan |e VerfasserIn |0 (DE-588)1130687643 |0 (DE-627)884888835 |0 (DE-576)486922367 |4 aut | |
| 700 | 1 | |a Holderbach, Stefan |e VerfasserIn |0 (DE-588)1183591632 |0 (DE-627)1663221324 |4 aut | |
| 700 | 1 | |a Voss, Yannik |d 1993- |e VerfasserIn |0 (DE-588)1183592469 |0 (DE-627)1663222495 |4 aut | |
| 700 | 1 | |a El Andari, Jihad |e VerfasserIn |0 (DE-588)1076495664 |0 (DE-627)834986752 |0 (DE-576)442630514 |4 aut | |
| 700 | 1 | |a Boulant, Steeve |e VerfasserIn |0 (DE-588)1130687430 |0 (DE-627)884888509 |0 (DE-576)48692243X |4 aut | |
| 700 | 1 | |a Meister, Michael |e VerfasserIn |0 (DE-588)1078792046 |0 (DE-627)839461402 |0 (DE-576)451890108 |4 aut | |
| 700 | 1 | |a Grimm, Dirk |e VerfasserIn |0 (DE-588)1016476671 |0 (DE-627)70553376X |0 (DE-576)352260645 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Molecular therapy. Methods & clinical development |d New York, NY : Nature Publishing Group, 2014 |g 12(2019), Seite 202-222 |h Online-Ressource |w (DE-627)863823203 |w (DE-600)2863173-0 |w (DE-576)475381483 |x 2329-0501 |7 nnas |a Novel chimeric gene therapy vectors based on adeno-associated virus and four different Mammalian bocaviruses |
| 773 | 1 | 8 | |g volume:12 |g year:2019 |g pages:202-222 |g extent:21 |a Novel chimeric gene therapy vectors based on adeno-associated virus and four different Mammalian bocaviruses |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.omtm.2019.01.003 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u http://www.sciencedirect.com/science/article/pii/S2329050119300063 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20190415 | ||
| 993 | |a Article | ||
| 994 | |a 2019 | ||
| 998 | |g 1016476671 |a Grimm, Dirk |m 1016476671:Grimm, Dirk |d 910000 |d 911700 |e 910000PG1016476671 |e 911700PG1016476671 |k 0/910000/ |k 1/910000/911700/ |p 15 |y j | ||
| 998 | |g 1078792046 |a Meister, Michael |m 1078792046:Meister, Michael |d 910000 |d 950000 |d 950900 |e 910000PM1078792046 |e 950000PM1078792046 |e 950900PM1078792046 |k 0/910000/ |k 1/910000/950000/ |k 2/910000/950000/950900/ |p 11 | ||
| 998 | |g 1130687430 |a Boulant, Steeve |m 1130687430:Boulant, Steeve |d 910000 |d 911700 |e 910000PB1130687430 |e 911700PB1130687430 |k 0/910000/ |k 1/910000/911700/ |p 10 | ||
| 998 | |g 1076495664 |a El Andari, Jihad |m 1076495664:El Andari, Jihad |d 910000 |d 911700 |e 910000PE1076495664 |e 911700PE1076495664 |k 0/910000/ |k 1/910000/911700/ |p 8 | ||
| 998 | |g 1183592469 |a Voss, Yannik |m 1183592469:Voss, Yannik |d 910000 |d 911700 |e 910000PV1183592469 |e 911700PV1183592469 |k 0/910000/ |k 1/910000/911700/ |p 7 | ||
| 998 | |g 1183591632 |a Holderbach, Stefan |m 1183591632:Holderbach, Stefan |d 910000 |d 911700 |e 910000PH1183591632 |e 911700PH1183591632 |k 0/910000/ |k 1/910000/911700/ |p 6 | ||
| 998 | |g 1130687643 |a Stanifer, Megan |m 1130687643:Stanifer, Megan |d 910000 |d 911700 |e 910000PS1130687643 |e 911700PS1130687643 |k 0/910000/ |k 1/910000/911700/ |p 4 | ||
| 998 | |g 140634401 |a Schneider, Marc |m 140634401:Schneider, Marc |d 910000 |d 950000 |d 950900 |e 910000PS140634401 |e 950000PS140634401 |e 950900PS140634401 |k 0/910000/ |k 1/910000/950000/ |k 2/910000/950000/950900/ |p 2 | ||
| 998 | |g 1160790612 |a Fakhiri, Julia |m 1160790612:Fakhiri, Julia |d 910000 |d 911700 |e 910000PF1160790612 |e 911700PF1160790612 |k 0/910000/ |k 1/910000/911700/ |p 1 |x j | ||
| 999 | |a KXP-PPN1663218870 |e 3421766975 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"name":{"displayForm":["Julia Fakhiri, Marc A. Schneider, Jens Puschhof, Megan Stanifer, Verena Schildgen, Stefan Holderbach, Yannik Voss, Jihad El Andari, Oliver Schildgen, Steeve Boulant, Michael Meister, Hans Clevers, Ziying Yan, Jianming Qiu, and Dirk Grimm"]},"person":[{"family":"Fakhiri","display":"Fakhiri, Julia","role":"aut","given":"Julia"},{"role":"aut","given":"Marc","display":"Schneider, Marc","family":"Schneider"},{"given":"Megan","role":"aut","display":"Stanifer, Megan","family":"Stanifer"},{"family":"Holderbach","given":"Stefan","role":"aut","display":"Holderbach, Stefan"},{"display":"Voss, Yannik","given":"Yannik","role":"aut","family":"Voss"},{"family":"El Andari","display":"El Andari, Jihad","role":"aut","given":"Jihad"},{"role":"aut","given":"Steeve","display":"Boulant, Steeve","family":"Boulant"},{"given":"Michael","role":"aut","display":"Meister, Michael","family":"Meister"},{"family":"Grimm","given":"Dirk","role":"aut","display":"Grimm, Dirk"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"origin":[{"dateIssuedKey":"2019","dateIssuedDisp":"18 January 2019"}],"recId":"1663218870","physDesc":[{"extent":"21 S."}],"id":{"eki":["1663218870"],"doi":["10.1016/j.omtm.2019.01.003"]},"relHost":[{"disp":"Novel chimeric gene therapy vectors based on adeno-associated virus and four different Mammalian bocavirusesMolecular therapy. Methods & clinical development","id":{"issn":["2329-0501"],"zdb":["2863173-0"],"eki":["863823203"]},"physDesc":[{"extent":"Online-Ressource"}],"note":["Gesehen am 25.06.20"],"type":{"bibl":"periodical","media":"Online-Ressource"},"titleAlt":[{"title":"Methods and clinical development"}],"recId":"863823203","origin":[{"publisherPlace":"New York, NY","dateIssuedDisp":"[2014]-","publisher":"Nature Publishing Group"}],"title":[{"title":"Molecular therapy","partname":"Methods & clinical development","title_sort":"Molecular therapy"}],"language":["eng"],"part":{"extent":"21","pages":"202-222","volume":"12","text":"12(2019), Seite 202-222","year":"2019"},"pubHistory":["1 (08. Jan. 2014)-"]}],"note":["Available online 18 January 2019","Gesehen am 15.04.2019"],"title":[{"title":"Novel chimeric gene therapy vectors based on adeno-associated virus and four different Mammalian bocaviruses","title_sort":"Novel chimeric gene therapy vectors based on adeno-associated virus and four different Mammalian bocaviruses"}],"language":["eng"]} | ||
| SRT | |a FAKHIRIJULNOVELCHIME1820 | ||